Implantable Cardiac Pacemaker Market, by Product Type (Single Chamber Pacemaker, Dual Chamber Pacemaker and Biventricular Pacemaker), by Application (Heart Block, Arrhythmia, Atrial fibrillation, Long QT Syndrome, Bradycardia, Tachycardia and Others), by End User (Hospitals, Emergency Care Centers and Others), and by Geography - Global Forecast to 2026

Global Implantable Cardiac Pacemaker Market – Global Industry Insights

Since the evolution of implantable cardiac pacemakers, cardiac pacing devices are extensively used to treat bradycardia (delayed or absent activation of the entire ventricle) and Cardiac Resynchronization Therapy (CRT). Implantable cardiac pacemakers are the small devices, which are placed inside the chest or abdomen in order to control abnormal heart rhythms. Pacemakers are also majorly used to treat arrhythmias: a problem with the rate of rhythm of heartbeat, in which heart beats too fast and sometimes beats too slowly causing irregular rhythm. 

Several market players in emerging economies such as Asia and Middle East are offering products with comparable performance levels to that of high-end implantable cardiac pacemakers at affordable costs. This is mainly attributed to factors such as increasing availability of skilled physicians and healthcare practitioners, lower costs incurred with medical facilities, and combined efforts of government and domestic players to increase patient access. Moreover, increasing prevalence of cardiovascular disease such as arrhythmia, atrial fibrillation, long QT syndrome, bradycardia, and tachycardia coupled with adoption of sedentary and unhealthy lifestyle are further expected to augment growth of implantable cardiac pacemaker market over the forecast period

The global implantable cardiac pacemaker market was valued at US$ 4.7 billion in 2017 and is expected to witness a CAGR of 7.1% over the forecast period (2018 – 2026).

Global Implantable Cardiac Pacemaker Market Share, By Product Type: 2017 & 2026

implantable cardiac pacemaker market

Source: Coherent Market Insights Analysis (2018)

Introduction of Advanced Pacemaker Technologies is Expected to Drive Growth of the Implantable Cardiac Pacemaker Market

Adoption of advanced technologies in cardiac pacemakers such as MRI safe-pacemakers, pacemakers with improved battery life, delay the progression of persistent Atrial Fibrillation (AF) in patients suffering from bradycardia and wireless automated technologies. This advancements are gaining significant traction of various market players of implantable cardiac pacemakers with affordable costs, which in turn are expected to drive growth of implantable cardiac pacemakers market. For instance, in February 2017, Abbott received the Food and Drug Administration (FDA) approval for its MR-conditional labeling for both of its products i.e. Assurity MRI pacemaker and the Tendril MRI pacing lead. Furthermore, introduction of advance technology such as wireless and automated pacemaker monitoring pacemakers are gaining significant traction among healthcare providers.

For instance, in 2016, Biotronik launched CardioMessenger Smart, portable monitoring device in the U.S. This system is about the size of a modern smartphone used to keep pacemaker, Implantable Cardioverter Defibrillator (ICD) and Insertable Cardiac Monitor (ICM) patients connected to their physician remotely. This CardioMessenger Smart helps to ensure patient compliance and the consistent transmission of data necessary for physicians to identify and prevent potential cardiac events. Thus, such wireless technologies are gaining traction of vendors, which is expected to drive the growth of the implantable cardiac pacemaker market

Increasing Prevalence of Cardiovascular Disease is Expected to Drive Growth of Implantable Cardiac Pacemaker Market

Increasing incidence of cardiovascular diseases is expected to boost growth of the implantable cardiac pacemakers market over the forecast period. According to the Centers for Disease Control and Prevention (CDC), August 2017 data findings, Atrial Fibrillation (AFib or AF) is most common type of heart arrhythmia, which affected an estimated 2.7 to 6.1 million people in the U.S. and the number is expected to increase in near future. Furthermore, Atrial Fibrillation cases increase with age and it is more prominent in men than women. Moreover, increasing number of geriatric population across the various regions worldwide along with high prevalence of heart disease is expected to propel demand for implantable cardiac pacemakers in the near future.

Furthermore, according to the data published in the Journal of the Formosan Medical Association, in November 2016, around half of the world population is living in Asia and geriatric population is growing at faster rate in Asia, which is increasing burden of AF in Asia. According to the same source, in 2050, around 72 million people are projected to suffer from AF patients in Asia, which is expected to be more than double the combined numbers of patients from Europe and the U.S. Furthermore, according to the World Health Organization (WHO), in 2015, around 17.7 million deaths were recorded due to cardiovascular diseases, out of which around 7.4 million deaths were caused due to coronary heart disease and 6.7 million deaths due to stroke. Furthermore, according to the American College of Cardiology, as of 2017, cardiovascular diseases accounts for around 800,000 deaths in the U.S and it remains the leading cause of death in the U.S.

However, implantable pacemakers associated infections in cardiac patients is hindering growth of the implantable cardiac pacemaker market. Pacemaker surgery is associated with swelling, bruising, bleeding, or infection of the area where the pacemaker was placed leading to blood vessel or nerve damage and adverse reaction of medicine used during the pacemaker implantation surgery, which may reduce the adoption of implantable cardiac implants in patients.

Some of the key players operating in implantable cardiac pacemaker market include Medtronic plc, BIOTRONIK, Inc., Boston Scientific Corporation, St. Jude Medical, Vitatron Holding B.V., Shree Pacetronix Ltd., MEDICO S.p.A., Lepu Medical Technology Co Ltd., LivaNova PLC, and Qinming Medical.

Implantable cardiac pacemaker is a small device implanted in the chest or abdomen for the treatment of abnormal heart rhythms, arrhythmia, heart block, and atrial fibrillation. Implantable cardiac pacemaker is evolved from battery-powered transistorized wearable pacemakers to current leadless pacemaker, an entire pacemaker which is placed within cardiac chambers. Cardiac pacemakers are used to treat abnormal electrical signaling in the heart, which causes arrhythmias. Implantable cardiac pacemaker use low-energy electrical signals to speed up the slow heartbeat, help to control an abnormal and fast heart rhythm, and prevents long QT syndrome, a disorder of the heart’s electrical activity, which causes sudden, uncontrollable, and dangerous arrhythmias.

Market Dynamics

Market players are engaged in developing novel pacemakers with ability to control the abnormal heart rhythm, monitor and record patient’s heart's electrical activity, blood temperature, and breathing rate. Technological advances in the field of implantable cardiac pacemakers along with increasing prevalence of cardiovascular disease is projected to drive the growth of implantable cardiac pacemaker market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of implantable cardiac pacemaker in medical sector and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global implantable cardiac pacemaker market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
  • Key companies covered as a part of this study include Medtronic plc, BIOTRONIK, Inc., Boston Scientific Corporation, St. Jude Medical, Vitatron Holding B.V., Shree Pacetronix Ltd., MEDICO S.p.A., Lepu Medical Technology Co Ltd., LivaNova PLC and Qinming Medical.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion and marketing tactics
  • The global implantable cardiac pacemaker market report caters to various stakeholders in this industry including investors, suppliers, implantable cardiac pacemakers manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the implantable cardiac pacemaker market.

Detailed Segmentation:

  • Global Implantable Cardiac Pacemaker Market, By Product Type:
    • Single Chamber Pacemaker
    • Dual Chamber Pacemaker
    • Biventricular Pacemaker
  • Global Implantable Cardiac Pacemaker Market, By Application:
    • Heart Block
    • Arrhythmia
    • Atrial fibrillation
    • Long QT Syndrome
    • Bradycardia
    • Tachycardia
    • Others
  • Global Implantable Cardiac Pacemaker Market, By End User:
    • Hospitals
    • Emergency Care Centers
    • Others
  • Global Implantable Cardiac Pacemaker Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Product Type:
        • Single Chamber Pacemaker
        • Dual Chamber Pacemaker
        • Biventricular Pacemaker
      • By Application
        • Heart Block
        • Arrhythmia
        • Atrial fibrillation
        • Long QT Syndrome
        • Bradycardia
        • Tachycardia
        • Others
      • By End User:
        • Hospitals
        • Emergency Care Centers 
        • Others
    • Europe
      • By Country:
        • Germany
        • France
        • Italy
        • UK
        • Spain
        • Russia
        • Rest of Europe
      • By Product Type:
        • Single Chamber Pacemaker
        • Dual Chamber Pacemaker
        • Biventricular Pacemaker
      • By Application
        • Heart Block
        • Arrhythmia
        • Atrial fibrillation
        • Long QT Syndrome
        • Bradycardia
        • Tachycardia
        • Others
      • By End User:
        • Hospitals
        • Emergency Care Centers 
        • Others
    • Asia Pacific
      • By Country:
        • China
        • India
        • Japan
        • South Korea
        • Australia
        • Rest of Asia Pacific
      • By Product Type:
        • Single Chamber Pacemaker
        • Dual Chamber Pacemaker
        • Biventricular Pacemaker
      • By Application
        • Heart Block
        • Arrhythmia
        • Atrial fibrillation
        • Long QT Syndrome
        • Bradycardia
        • Tachycardia
        • Others
      • By End User:
        • Hospitals
        • Emergency Care Centers 
        • Others
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Product Type:
        • Single Chamber Pacemaker
        • Dual Chamber Pacemaker
        • Biventricular Pacemaker
      • By Application
        • Heart Block
        • Arrhythmia
        • Atrial fibrillation
        • Long QT Syndrome
        • Bradycardia
        • Tachycardia
        • Others
      • By End User:
        • Hospitals
        • Emergency Care Centers 
        • Others
    • Latin America
      • By Country:
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
      • By Product Type:
        • Single Chamber Pacemaker
        • Dual Chamber Pacemaker
        • Biventricular Pacemaker
      • By Application
        • Heart Block
        • Arrhythmia
        • Atrial fibrillation
        • Long QT Syndrome
        • Bradycardia
        • Tachycardia
        • Others
      • By End User:
        • Hospitals
        • Emergency Care Centers 
        • Others
    • Africa
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
      • By Product Type:
        • Single Chamber Pacemaker
        • Dual Chamber Pacemaker
        • Biventricular Pacemaker
      • By Application
        • Heart Block
        • Arrhythmia
        • Atrial fibrillation
        • Long QT Syndrome
        • Bradycardia
        • Tachycardia
        • Others
      • By End User:
        • Hospitals
        • Emergency Care Centers 
        • Others
  • Company Profiles
    • Medtronic plc *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments
      • Strategies
    • BIOTRONIK, Inc.
    • Boston Scientific Corporation
    • Jude Medical
    • Vitatron Holding B.V.
    • Shree Pacetronix Ltd.
    • MEDICO S.p.A.
    • Lepu Medical Technology Co Ltd.
    • LivaNova PLC
    • Qinming Medical

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet By Product Type
      • Market Snippet By Application
      • Market Snippet By End-User
      • Market Snippet By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Regulatory Scenario
      • Market Trends
      • Epidemiology
      • Merger and Acquisitions
      • New Product Approvals/Launch
      • PEST Analysis
      • Porter’s Analysis
  4. Global Implantable Cardiac Pacemaker Market, By Product Type, 2016 - 2026 (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2026 (%)
      • Y-O-Y Growth Analysis, 2017 - 2026
      • Segment Trends
    • Single Chamber Pacemaker
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
    • Dual Chamber Pacemaker
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
    • Biventricular Pacemaker
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
  5. Global Implantable Cardiac Pacemaker Market, By Application, 2016 - 2026 (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2026 (%)
      • Y-O-Y Growth Analysis, 2017 - 2026
      • Segment Trends
    • Heart Block
      • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-O-Y Growth Analysis, 2017 - 2026
    • Arrhythmia
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
    • Atrial fibrillation
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
    • Long QT Syndrome
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
    • Bradycardia
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
    • Tachycardia
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
  6. Global Implantable Cardiac Pacemaker Market, By End-User, 2016 - 2026 (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2026 (%)
      • Y-O-Y Growth Analysis, 2017 - 2026
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
    • Emergency Care Centers
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
  7. Global Implantable Cardiac Pacemaker Market, By Regions, 2016 - 2026 (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2017 and 2026 (%)
      • Y-O-Y Growth Analysis, For Regions, 2017 - 2026
    • North America
      • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Million)
      • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
      • Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
      • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Million)
      • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
      • Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
      • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Million)
      • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
      • Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
      • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Million)
      • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
      • Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
      • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Million)
      • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
      • Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
      • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
        • Northern Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Million)
      • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
      • Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
      • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
  8. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Medtronic plc
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • BIOTRONIK, Inc.
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Boston Scientific Corporation
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • St. Jude Medical
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Vitatron Holding B.V.
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Shree Pacetronix Ltd.
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • MEDICO S.p.A.
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Lepu Medical Technology Co Ltd.
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • LivaNova PLC
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Qinming Medical
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
    • Analyst Views
  9. Section
    • References
    • Analyst Views
    • Research Methodology
    • About Us and Sales Contact

*Browse 22 market data tables and 39 figures on "Implantable Cardiac Pacemaker Market - Global forecast to 2026”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.